BioVoice News July 2017 Issue 2 Volume 2 | Page 12

The innovation landscape within the bioscience industry has been evolving in last two decades . What are they key ingredients that could accelerate the translational research ?
Have the technology transfers and interface between industry and academia in India improved ? How can we make it better ?

face to face

The innovation ecosystem is gradually evolving . Emphasis on the same through government support bodes well for the country

on different variables of varied merits . Our performance likewise varies over different metrics . On some parameters we fare quite well .
Towards a few parameters like education , we would need to strategize both from a medium and long term perspective to address various deficiencies . In its current format , a few metrics would be a function of government investments in education and infrastructure . There is also a need to revisit the structure of the ranking parameters to better reflect the actual state of development in a country .
The innovation landscape within the bioscience industry has been evolving in last two decades . What are they key ingredients that could accelerate the translational research ?
Yes , the innovation ecosystem is gradually evolving . Emphasis on the same through Government support bodes well for the country . The research establishments and the academia should increasingly pay more attention to IP creation and research translation through a mix of incentives – performance metrics , rewards , linkage with research grants , enhanced collaboration with industry etc . New approaches like the the FTT projects in CSIR are enabling a cultural change towards translation and commercialization .
Institutional mechanism like TTOs , Research Parks , incubators should be strengthened on capacity and resources to accelerate and sustain research translation from academia and research establishments .
Have the technology transfers and interface between industry and academia in India improved ? How can we make it better ?
It ’ s still at modest
12 BioVoiceNews | July 2017